Inactive Instrument

Insiders ObsEva SA Swiss Exchange

Equities

Insider Buy: Obseva	23-04-11	MT
ObsEva Names New CEO From May, Appoints Interim Chairman	23-03-13	MT
ObsEva Names New Interim Chairman, CEO as Reorganization Continues	23-03-13	MT
ObsEva SA Announces CEO Changes, Effective on or About May 1, 2023	23-03-13	CI
ObsEva SA Announces Executive Changes	23-03-13	CI
Insider Buy: Obseva	23-03-02	MT
ObsEva to Delist From Nasdaq, Consolidate Swiss Operations; Shares Fall	23-02-24	MT
ObsEva SA Announces Board Changes	23-02-24	CI
Switzerland's ObsEva Shuffles Senior Management Under Strategic Reorganization Plan	23-02-24	MT
ObsEva SA Announces Executive Changes	23-02-24	CI
ObsEva SA Announces Executive Changes	23-02-24	CI
Exchange-Traded Funds Preview: Encouraging Data Expectations Lifting ETFs, Equities Futures	22-11-22	MT
ObsEva to Terminate Chief Strategy Officer, 70% of Staff Amid Restructuring	22-09-13	MT
ObsEva's Chief Scientific Officer to Leave in September	22-07-29	MT
ObsEva SA Announces Management Change	22-07-29	CI
ObsEva Chief Administrative Officer Steps Down From Executive Committee	22-07-27	MT
ObsEva SA Announces Resignation of Fabien De Ladonchamps from Executive Committee	22-07-27	CI
ObsEva Chair Steps Down; Successor Named	22-05-19	MT
ObsEva Announces Appointment of Annette Clancy as Chair of the Board of Directors	22-05-19	CI
ObsEva Appoints New Chief Clinical Officer	22-05-02	MT

No results for this search